PDK1 and ovarian carcinoma: Similarly, Zhang et al. [149] reported the potential effects of a coumarin compound, dicumarol, that inhibits pyruvate dehydrogenase kinase 1 (PDK1) and targets multiple malignant behaviors of ovarian cancer cells.